Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Nephrology | Urology | Family Medicine
Disease Category: Benign Prostatic Hyperplasia (Enlarged Prostate)
Location: United States, IN

Clinical Trial Details

Overview

Research Study Summary

A Phase III multi-center prospective randomized, parallel-group, placebo-controlled, double-blind, clinical evaluation of NX-1207 for the treatment of BPH (Benign Prostatic Hyperplasia, or Enlarged Prostate)

Purpose

The purpose of this study is to evaluate the efficacy and safety of NX-1207 and to see if it could be useful for men with BPH. The study treatment will consist of either an injection of NX-1207 or of a placebo into the prostate. If you end up receiving the placebo, you will be offered the chance to receive NX-1207 at the end of the study. The study will last for 12 months.

Inclusions:

  • Male ≥ 45 years of age
  • History of BPH for at least 1 year

Exclusions:

  • Acute or chronic Prostatitis in the past 12 months
  • Urinary Tract Infections more than once in the past 12 months
  • Previous surgical or invasive prostate treatments such as TURP, TUMT, and TUNA, laser or any minimally invasive treatments.
  • History of urinary retention in the past 12 months
  • Prostate or bladder cancer
  • PSA ≥ 10 ng.ml

To Learn more
Phase

3

Gender

Male

Age

45 and up

Overall Status

Recruiting

Facility Type

N/A

Contact

Debbie Johnson, CCRC, Director of Research
First Urology, PSC
101 Hospital Blvd.
Jeffersonville, IN 47130
Phone: (812) 206-8161
Fax: (812) 288-2612

View Map

Research Center Information: First Urology, PSC

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 178190

Date Last Changed: May 2, 2014


DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.